Doximity, Inc. (NASDAQ:DOCS) Position Decreased by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. decreased its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 7.3% in the 4th quarter, HoldingsChannel.com reports. The firm owned 119,168 shares of the company’s stock after selling 9,350 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Doximity were worth $3,341,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the business. Weiss Multi Strategy Advisers LLC boosted its position in shares of Doximity by 6.9% during the 1st quarter. Weiss Multi Strategy Advisers LLC now owns 4,810 shares of the company’s stock valued at $251,000 after purchasing an additional 310 shares in the last quarter. Royal Bank of Canada boosted its holdings in shares of Doximity by 0.7% in the third quarter. Royal Bank of Canada now owns 66,135 shares of the company’s stock worth $1,404,000 after buying an additional 455 shares during the period. Creative Financial Designs Inc. ADV boosted its holdings in shares of Doximity by 16.7% in the fourth quarter. Creative Financial Designs Inc. ADV now owns 3,301 shares of the company’s stock worth $93,000 after buying an additional 473 shares during the period. EFG Asset Management Americas Corp. boosted its holdings in shares of Doximity by 7.3% in the second quarter. EFG Asset Management Americas Corp. now owns 7,125 shares of the company’s stock worth $242,000 after buying an additional 484 shares during the period. Finally, Xponance Inc. boosted its holdings in shares of Doximity by 2.7% in the third quarter. Xponance Inc. now owns 19,522 shares of the company’s stock worth $414,000 after buying an additional 508 shares during the period. Institutional investors own 87.19% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently commented on the stock. Truist Financial boosted their price target on shares of Doximity from $28.00 to $29.00 and gave the company a “hold” rating in a report on Friday, February 9th. Barclays assumed coverage on shares of Doximity in a report on Wednesday, January 3rd. They set an “equal weight” rating and a $31.00 price target on the stock. JPMorgan Chase & Co. boosted their price target on shares of Doximity from $22.00 to $25.00 and gave the company an “underweight” rating in a report on Friday, March 15th. SVB Leerink assumed coverage on shares of Doximity in a report on Monday, February 26th. They set a “market perform” rating and a $32.00 price target on the stock. Finally, Wells Fargo & Company boosted their price target on shares of Doximity from $25.00 to $27.00 and gave the company an “equal weight” rating in a report on Friday, February 9th. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $28.82.

Doximity Trading Up 0.5 %

Shares of NASDAQ:DOCS opened at $25.18 on Thursday. The stock has a market capitalization of $4.70 billion, a PE ratio of 38.15, a P/E/G ratio of 3.20 and a beta of 1.17. Doximity, Inc. has a 1 year low of $19.71 and a 1 year high of $37.10. The firm has a fifty day moving average price of $27.68 and a 200 day moving average price of $26.08.

Doximity (NASDAQ:DOCS) last released its earnings results on Thursday, February 8th. The company reported $0.25 earnings per share for the quarter, topping analysts’ consensus estimates of $0.19 by $0.06. The firm had revenue of $135.28 million during the quarter, compared to analyst estimates of $127.46 million. Doximity had a net margin of 29.39% and a return on equity of 16.08%. On average, sell-side analysts forecast that Doximity, Inc. will post 0.72 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Doximity news, Director Kira Scherer Wampler sold 2,500 shares of the business’s stock in a transaction on Monday, April 1st. The shares were sold at an average price of $26.97, for a total transaction of $67,425.00. Following the completion of the transaction, the director now owns 10,258 shares of the company’s stock, valued at approximately $276,658.26. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 39.40% of the company’s stock.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.